Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors

The aim of this work is to assess if cumulative dose (CD) and dose intensity (DI) of everolimus may affect survival of advanced pancreatic neuroendocrine tumors (PNETs) patients. One hundred and sixteen patients (62 males and 54 females, median age 55 years) with advanced PNETs were treated with eve...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Berardi, Rossana, Torniai, Mariangela, Pusceddu, Sara, Spada, Francesca, Ibrahim, Toni, Brizzi, Maria Pia, Antonuzzo, Lorenzo, Ferolla, Piero, Panzuto, Francesco, Silvestris, Nicola, Partelli, Stefano, Ferretti, Benedetta, Freddari, Federica, Gucciardino, Calogero, Testa, Enrica, Concas, Laura, Murgioni, Sabina, Bongiovanni, Alberto, Zichi, Clizia, Riva, Nada, Rinzivillo, Maria, Brunetti, Oronzo, Giustini, Lucio, Di Costanzo, Francesco, Delle Fave, Gianfranco, Fazio, Nicola, De Braud, Filippo, Falconi, Massimo, Cascinu, Stefano
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2017
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504331/
https://ncbi.nlm.nih.gov/pubmed/28547856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1028
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items